←Back to Expert Scholars
Translational Medicine / 转化医学Nivolumab Lung Cancer Trials
Luis Paz-Ares
MD, PhD
🏢Hospital Universitario 12 de Octubre🌐Spain
Chair, Medical Oncology Department
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Luis Paz-Ares led CheckMate-227 and CheckMate-9LA trials evaluating nivolumab and ipilimumab combinations in advanced non-small cell lung cancer. He has been central to combination immunotherapy development and chairs medical oncology at Hospital 12 de Octubre in Madrid.
Share:
🧪Research Fields 研究领域
CheckMate-227
nivolumab ipilimumab
first-line NSCLC
small cell lung cancer
Spanish lung cancer group
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Luis Paz-Ares 的研究动态
Follow Luis Paz-Ares's research updates
留下邮箱，当我们发布与 Luis Paz-Ares（Hospital Universitario 12 de Octubre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment